This is an AstraZeneca UK website
The content on this website is intended for UK Healthcare Professionals only. The website contains both promotional and non-promotional content.
Lung
LEAP AI
Use of AI in earlier lung cancer detection - Clinithink and St Barts
December 2025 | GB-72034
QURE AI
Use of AI in earlier lung cancer detection - Qure AI and Great Manchester Cancer Alliance
December 2025 | GB-72035
EGFR Quic DNA
Epidermal Growth Factor Receptor (EGFR) in lung cancer
December 2025 | GB-72036
Breast
BRCA genes and me
(a digital patient empowerment project)
December 2025 | GB-72038
Upper GI
New partnership coming soon
Other partnerships
Targeted medicines:
Art therapy CLL
December 2025 | GB-72039
Optimising pathways:
Tackling health inequalities in CLL
December 2025 | GB-72040
Optimising pathways:
NHS capacity
December 2025 | GB-72041
Get in touch
Cancer is a problem we can solve, but we can't solve it alone.
For further information on how AstraZeneca UK can collaborate on shared goals and priorities, please contact
Together; we can realise AstraZeneca's bold ambition, to one day, eliminate cancer as a cause of death.
November 2025 | GB-71484
This website is intended for UK healthcare professionals only
© AstraZeneca 2025. All rights reserved.
GB-72601 December 2025
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033.
© AstraZeneca 2025. All rights reserved.
GB-72601 December 2025